David Matthew Stark, Executive VP Chief Legal Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 2,358 shares at $18.38 ($43K) on 2018-03-19, disclosed to the SEC on 2018-03-20.
Scheduled sale ($43k) by Executive VP Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2023-03-02 | $1.3M | — | Filing → |
| TEVA | SELL | 2022-07-29 | $1.1M | — | Filing → |
| TEVA | SELL | 2022-03-08 | $435K | — | Filing → |